ORA is a vertically integrated telehealth platform, delivering over 250,000 consultations and uninterrupted monthly growth since its launch in 2021.
ORA has launched three brands serving patients living with chronic conditions, aiming to make treatment more accessible, convenient and personal. “Modules” is a first-to-market personalised online dermatology service; “andSons” offers male health solutions; while “OVA” delivers female reproductive healthcare.
With the new round of funding, ORA will seek to expand its presence into new territories, both geography and new offerings-wise. ORA plans to bring its brands across 1300 tier one retail stores later this year, aside from looking at expansion opportunities into regions like the Gulf.
